Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Diagnosoft was a medical imaging software company that specialized in advanced cardiovascular magnetic resonance (CMR) analysis. Founded by researchers from Johns Hopkins University, the company developed patented algorithms to quantify myocardial strain and cardiac function with high precision. Its flagship software products, including Virtue and HARP, automated the processing of cardiac MRI scans, enabling clinicians to detect early signs of heart failure and other cardiovascular diseases. Diagnosoft's technology was widely adopted in clinical research and pharmaceutical trials to evaluate the cardiac impact of therapeutic interventions. The company's assets and intellectual property were eventually acquired by Myocardial Solutions, which continues to advance the technology.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Diagnosoft.